Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 172.35%227.59M | ---- | -141.62%-314.57M | ---- | -75.23%755.73M | ---- | 59.68%3.05B | ---- | -52.99%1.91B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -6.95%-274.99M | ---- | 22.20%-257.13M | ---- | 5.71%-330.51M | ---- | -25.12%-350.51M | ---- | -66.64%-280.15M |
| Dividend (income)- adjustment | ---- | 50.24%-13.75M | ---- | -227.67%-27.63M | ---- | 64.23%-8.43M | ---- | -98.68%-23.57M | ---- | 85.55%-11.87M |
| Investment loss (gain) | ---- | -25.76%-158.81M | ---- | -246.94%-126.28M | ---- | 86.99%-36.4M | ---- | 8.33%-279.67M | ---- | -34.21%-305.09M |
| Attributable subsidiary (profit) loss | ---- | -306.31%-2.85M | ---- | 145.36%1.38M | ---- | -128.96%-3.04M | ---- | 682.70%10.5M | ---- | 102.64%1.34M |
| Impairment and provisions: | ---- | -70.26%152.67M | ---- | -18.23%513.3M | ---- | 81.90%627.76M | ---- | 41,530.49%345.12M | ---- | -115.92%-833K |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -20.11%249.84M | ---- | 39.50%312.72M | ---- | --224.18M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 15.70%47.6M | ---- | -56.09%41.15M | ---- | 1,158.71%93.71M | ---- | ---8.85M | ---- | ---- |
| -Other impairments and provisions | ---- | -52.74%105.06M | ---- | 0.44%222.31M | ---- | 70.54%221.34M | ---- | 15,681.27%129.79M | ---- | -115.92%-833K |
| Revaluation surplus: | ---- | -82.13%28.47M | ---- | -40.10%159.36M | ---- | 357.85%266.05M | ---- | -171.95%-103.18M | ---- | 244.71%143.4M |
| -Derivative financial instruments fair value (increase) | ---- | -141.75%-26.26M | ---- | 55.29%62.9M | ---- | 1,368.46%40.5M | ---- | -102.12%-3.19M | ---- | 34.92%150.65M |
| -Other fair value changes | ---- | -43.26%54.73M | ---- | -57.23%96.46M | ---- | 325.58%225.55M | ---- | -1,278.53%-99.99M | ---- | 96.56%-7.25M |
| Asset sale loss (gain): | ---- | 96.10%-29.83M | ---- | 39.88%-764.15M | ---- | -3,265.19%-1.27B | ---- | 96.02%-37.77M | ---- | -741.58%-950.21M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | -3,917.84%-802.12M | ---- | 89.70%-19.96M | ---- | ---193.77M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 99.56%-3.16M | ---- | -47.17%-722.26M | ---- | -2,382.79%-490.75M | ---- | 97.39%-19.77M | ---- | -531.03%-756.76M |
| -Loss (gain) from selling other assets | ---- | 36.34%-26.67M | ---- | -292.45%-41.9M | ---- | 1,011.80%21.77M | ---- | 513.79%1.96M | ---- | -95.45%319K |
| Depreciation and amortization: | ---- | -20.74%1.1B | ---- | 8.95%1.39B | ---- | 13.05%1.28B | ---- | -2.24%1.13B | ---- | -3.37%1.16B |
| -Amortization of intangible assets | ---- | 0.05%69.89M | ---- | 2.37%69.86M | ---- | 868.45%68.24M | ---- | -6.37%7.05M | ---- | -39.65%7.53M |
| -Other depreciation and amortization | ---- | -54.86%-6.33M | ---- | 80.38%-4.09M | ---- | 6.74%-20.83M | ---- | -33.26%-22.33M | ---- | 2.02%-16.76M |
| Financial expense | ---- | 0.23%426.04M | ---- | -24.05%425.06M | ---- | 45.69%559.67M | ---- | 120.66%384.15M | ---- | 21.46%174.09M |
| Exchange Loss (gain) | ---- | -5.90%25.77M | ---- | 204.04%27.39M | ---- | -171.57%-26.32M | ---- | 186.73%36.78M | ---- | -225.19%-42.41M |
| Special items | ---- | 394.35%11.1M | ---- | --2.25M | ---- | ---- | ---- | ---- | ---- | ---1.33B |
| Adjustment items | ---- | -54.86%-6.33M | ---- | 80.38%-4.09M | ---- | 6.74%-20.83M | ---- | -33.26%-22.33M | ---- | 2.02%-16.76M |
| Operating profit before the change of operating capital | ---- | 44.90%1.49B | ---- | -42.62%1.03B | ---- | -56.76%1.79B | ---- | 816.06%4.14B | ---- | -90.26%452.11M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 1,044.04%1.99B | ---- | 196.45%174.02M | ---- | 59.05%-180.43M | ---- | ---440.64M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | 111.37%92.51M | ---- | -915.96%-813.91M | ---- | 94.36%-80.11M | ---- | ---1.42B | ---- | ---- |
| Accounts payable increase (decrease) | ---- | -327.90%-285.39M | ---- | 104.16%125.23M | ---- | -407.11%-3.01B | ---- | ---593.57M | ---- | ---- |
| Special items for working capital changes | ---- | -551.50%-393.56M | ---- | -94.90%87.17M | ---- | 3,357.22%1.71B | ---- | ---52.46M | ---- | ---- |
| Cash from business operations | 45.85%2.09B | 382.17%2.89B | 102.17%1.44B | 162.08%600.08M | -5.66%710.4M | -86.00%228.97M | 194.36%753.01M | 261.67%1.64B | -289.53%-798.01M | -69.86%452.11M |
| Other taxs | -83.29%-177.08M | 16.91%-113.73M | -2,829.41%-96.61M | 28.27%-136.87M | 94.95%-3.3M | 64.74%-190.81M | 63.03%-65.36M | -23.67%-541.13M | -69.59%-176.77M | 70.05%-437.55M |
| Interest received - operating | -44.27%81.17M | 3.59%244.26M | 34.19%145.65M | 57.93%235.79M | 26.67%108.53M | 4.76%149.3M | 4.48%85.68M | -7.30%142.52M | -12.48%82M | 122.41%153.75M |
| Interest paid - operating | 36.90%-146.3M | 5.87%-425.81M | -6.90%-231.84M | 7.41%-452.37M | -3.24%-216.87M | -21.95%-488.56M | -19.35%-210.06M | -40.50%-400.62M | 2.90%-176.01M | -87.60%-285.15M |
| Net cash from operations | 47.80%1.85B | 953.49%2.6B | 109.33%1.25B | 181.90%246.62M | 6.30%598.77M | -136.02%-301.11M | 152.70%563.27M | 815.40%835.9M | -566.24%-1.07B | -165.84%-116.84M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 45.40%9.47M | -10.04%13.03M | 5.17%6.51M | -56.30%14.48M | -69.83%6.19M | -71.60%33.13M | -71.68%20.53M | 50.43%116.67M | 46.14%72.49M | 339.38%77.56M |
| Dividend received - investment | 210.52%9.12M | ---- | -82.76%2.94M | --4.05M | --17.04M | ---- | ---- | --9.6M | --9.6M | ---- |
| Loan receivable (increase) decrease | 207.79%91.16M | -439,160.98%-180.02M | -529.07%-84.57M | 100.18%41K | -75.44%19.71M | 85.50%-22.17M | 124.38%80.25M | 41.04%-152.82M | -393.86%-329.14M | 33.39%-259.19M |
| Decrease in deposits (increase) | ---- | -74.94%127.54M | -22.14%1.09B | 207.34%508.96M | 241.41%1.4B | -155.16%-474.16M | ---990M | -101.37%-185.83M | ---- | 11,594.21%13.53B |
| Sale of fixed assets | -58.10%28.69M | -98.54%11.05M | 15,500.68%68.49M | 1,409.78%756.04M | --439K | 551.35%50.08M | ---- | 6,703.54%7.69M | ---- | -99.94%113K |
| Purchase of fixed assets | 14.75%-636.41M | -81.55%-1.32B | -139.39%-746.52M | 64.51%-727.21M | 67.91%-311.84M | -50.94%-2.05B | -81.48%-971.76M | -31.46%-1.36B | -383.69%-535.47M | -61.66%-1.03B |
| Selling intangible assets | --10.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | 56.93%-1.14M | 99.68%-2.42M | 99.65%-2.64M | -600.57%-746.92M | -10,302.38%-751.26M | -5,199.01%-106.62M | -2,526.18%-7.22M | 99.89%-2.01M | 99.98%-275K | -23.22%-1.78B |
| Sale of subsidiaries | ---- | -28.60%214.2M | -28.60%214.2M | -72.89%300M | -72.36%300M | 1,291.14%1.11B | 1,264.12%1.09B | 33.32%79.55M | --79.55M | 635.70%59.67M |
| Acquisition of subsidiaries | ---86.14M | ---20.08M | ---- | ---- | ---- | 2,127.18%168.2M | --232.3M | 108.52%7.55M | ---- | ---88.61M |
| Recovery of cash from investments | -70.08%11.12M | 151.28%119.62M | 148.49%37.17M | -26.85%47.6M | -125.55%-76.66M | -94.53%65.08M | 529.36%300.04M | 1,548.84%1.19B | 8.48%47.67M | -45.24%72.15M |
| Cash on investment | 45.77%-501.73M | 82.63%-40.38M | -380.95%-925.2M | -116.69%-232.41M | -387.77%-192.37M | 154.98%1.39B | 1,006.59%66.85M | 81.24%-2.53B | 101.98%6.04M | -684.23%-13.5B |
| Other items in the investment business | 83.60%-12.35M | 102.93%17.57M | -156.58%-75.29M | -562.40%-598.64M | 129.66%133.07M | -1,000.91%-90.37M | -121.46%-448.68M | 99.31%-8.21M | 176.42%2.09B | -131.91%-1.18B |
| Net cash from investment operations | -159.75%-1.08B | -57.28%-1.06B | -176.23%-414.91M | -1,021.05%-674M | 186.06%544.32M | 102.59%73.18M | -143.88%-632.5M | 31.20%-2.83B | 124.56%1.44B | -1,525.62%-4.11B |
| Net cash before financing | -7.60%774.83M | 459.87%1.54B | -26.64%838.52M | -87.51%-427.38M | 1,751.12%1.14B | 88.56%-227.93M | -118.58%-69.23M | 52.88%-1.99B | 106.60%372.51M | -1,324.26%-4.23B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -27.20%12.86B | -33.47%19.92B | -1.68%17.67B | 9.43%29.93B | 0.46%17.97B | -2.57%27.35B | -1.27%17.89B | 29.03%28.08B | 43.23%18.12B | 29.38%21.76B |
| Refund | 3.54%-14.12B | 32.01%-18.99B | 13.05%-14.64B | 4.33%-27.94B | -6.76%-16.83B | -15.08%-29.2B | -12.31%-15.77B | -52.70%-25.38B | -125.58%-14.04B | -21.24%-16.62B |
| Dividends paid - financing | ---21.07M | -73.33%-198.92M | ---- | 78.55%-114.76M | 39.96%-7.27M | 16.90%-534.9M | 32.74%-12.11M | -17.52%-643.65M | -120.94%-18M | 50.97%-547.72M |
| Absorb investment income | ---- | -1,096.53%-39.86M | --5M | -97.50%4M | ---- | 264.23%159.78M | --49M | -71.47%43.87M | ---- | 25,962.71%153.77M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | --131.91M | 137.35%49.22M | ---- | ---131.8M | ---- |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---301.74M | ---1.04B | ---- | ---- | ---- |
| Other items of the financing business | 230.20%2.78B | -3,480.19%-2.31B | -958.49%-2.14B | 0.59%68.42M | --248.81M | -93.71%68.02M | ---- | 162.98%1.08B | -418.08%-2.8B | -2,182.91%-1.72B |
| Net cash from financing operations | 68.17%1.49B | -185.31%-1.65B | -35.53%883.64M | 182.64%1.94B | 17.82%1.37B | -174.09%-2.34B | 3.13%1.16B | 4.84%3.16B | -80.79%1.13B | 45.88%3.02B |
| Effect of rate | -133.81%-2.31M | 176.72%11.5M | -75.24%6.83M | -121.99%-14.99M | -41.91%27.59M | 338.98%68.14M | 612.85%47.5M | -142.54%-28.51M | -150.85%-9.26M | 329.62%67.02M |
| Net Cash | 31.28%2.26B | -107.51%-113.27M | -31.49%1.72B | 158.68%1.51B | 129.74%2.51B | -319.80%-2.57B | -27.09%1.09B | 196.48%1.17B | 544.29%1.5B | -168.47%-1.21B |
| Begining period cash | -2.81%3.52B | 70.28%3.62B | 70.28%3.62B | -54.08%2.12B | -54.08%2.12B | 32.73%4.63B | 32.73%4.63B | -24.72%3.49B | -24.72%3.49B | 62.76%4.63B |
| Cash at the end | 8.00%5.77B | -2.81%3.52B | 14.59%5.35B | 70.28%3.62B | -19.11%4.67B | -54.08%2.12B | 15.89%5.77B | 32.73%4.63B | 1.95%4.98B | -24.72%3.49B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.